Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Aetna

(

AET

) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.2%. By the end of trading, Aetna rose $0.71 (1.1%) to $64.81 on average volume. Throughout the day, 2,983,251 shares of Aetna exchanged hands as compared to its average daily volume of 2,712,600 shares. The stock ranged in a price between $64.05-$65.39 after having opened the day at $64.17 as compared to the previous trading day's close of $64.10. Other companies within the Health Services industry that increased today were:

Retractable Technologies

(

RVP

), up 18.3%,

CardioNet

(

BEAT

), up 14.1%,

InspireMD

(

NSPR

), up 11.4% and

IsoRay

(

ISR

), up 11.3%.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $24.1 billion and is part of the health care sector. Shares are up 39.8% year to date as of the close of trading on Monday. Currently there are 12 analysts that rate Aetna a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates

Aetna

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, attractive valuation levels and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

On the negative front,

BioScrip

(

BIOS

), down 18.6%,

Arrhythmia Research Technology

(

HRT

), down 6.7%,

Baxano Surgical

(

BAXS

), down 5.6% and

ZELTIQ Aesthetics

(

ZLTQ

), down 4.6% , were all laggards within the health services industry with

Covidien

(

COV

) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null